Clinical Trial: A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult Participants

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07604558) titled 'A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult Participants' on May 18.

Brief Summary: This study will assess the adverse events, tolerability, and how bretisilocin intramuscular (IM) Injection moves through the body of healthy adult Japanese, Han Chinese, and Non-Asian volunteers participants.

Study Start Date: May 26

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: Bretisilocin

Intramuscular Injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Published by HT Digital Content Services with permission from Healt...